This content is restricted to site members. If you are an existing user, please log in. New users may register below.
New drug clears psoriasis in clinical trials
About 80 percent of patients with moderate to severe psoriasis saw their disease completely or almost completely cleared with a new drug called ixekizumab, according to three large, long-term clinical